BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18001116)

  • 1. Mechanistic insights into the chemistry of RuII complexes containing Cl and DMSO ligands.
    Mola J; Romero I; Rodríguez M; Bozoglian F; Poater A; Solà M; Parella T; Benet-Buchholz J; Fontrodona X; Llobet A
    Inorg Chem; 2007 Dec; 46(25):10707-16. PubMed ID: 18001116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Ru complexes containing the N-tridentate bpea and phosphine ligands: consequences of meridional vs facial geometry.
    Mola J; Rodríguez M; Romero I; Llobet A; Parella T; Poater A; Duran M; Solà M; Benet-Buchholz J
    Inorg Chem; 2006 Dec; 45(26):10520-9. PubMed ID: 17173407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, structure, and spectroscopic, photochemical, redox, and catalytic properties of ruthenium(II) isomeric complexes containing dimethyl sulfoxide, chloro, and the dinucleating bis(2-pyridyl)pyrazole ligands.
    Sens C; Rodríguez M; Romero I; Llobet A; Parella T; Sullivan BP; Benet-Buchholz J
    Inorg Chem; 2003 Mar; 42(6):2040-8. PubMed ID: 12639139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E; Sitkowski J; Kawecki R; Kozerski L; Bocian W; Pazderski L; Priebe W
    Dalton Trans; 2008 Aug; (31):4129-37. PubMed ID: 18688431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.
    Reisner E; Arion VB; Eichinger A; Kandler N; Giester G; Pombeiro AJ; Keppler BK
    Inorg Chem; 2005 Sep; 44(19):6704-16. PubMed ID: 16156629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures and DFT calculations of new chlorido-dimethylsulfoxide-M(III) (M = Ir, Ru, Rh) complexes with the N-pyrazolyl pyrimidine donor ligand: kinetic vs. thermodynamic isomers.
    Cánaves MM; Cabra MI; Bauzá A; Cañellas P; Sánchez K; Orvay F; García-Raso A; Fiol JJ; Terrón A; Barceló-Oliver M; Ballester P; Mata I; Molins E; Hussain F; Frontera A
    Dalton Trans; 2014 May; 43(17):6353-64. PubMed ID: 24599509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
    Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
    Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(II)-mediated coupling reaction of acetonitrile with 1H-indazole.
    Reisner E; Arion VB; Rufińska A; Chiorescu I; Schmid WF; Keppler BK
    Dalton Trans; 2005 Jul; (14):2355-64. PubMed ID: 15995743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New ruthenium(II) complexes with enantiomerically pure bis- and tris(pinene)-fused tridentate ligands. Synthesis, characterization and stereoisomeric analysis.
    Sala X; Poater A; von Zelewsky A; Parella T; Fontrodona X; Romero I; Solà M; Rodríguez M; Llobet A
    Inorg Chem; 2008 Sep; 47(18):8016-24. PubMed ID: 18693683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropisomerization, C-H activation, and dissociative substitution at some biphenyl platinum(II) complexes.
    Plutino MR; Scolaro LM; Albinati A; Romeo R
    J Am Chem Soc; 2004 May; 126(20):6470-84. PubMed ID: 15149244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diorganoruthenium complexes incorporating noninnocent [C(6)H(2)(CH(2)ER(2))(2)-3,5](2)(2-) (E = N, P) bis-pincer bridging ligands: synthesis, spectroelectrochemistry, and DFT studies.
    Gagliardo M; Amijs CH; Lutz M; Spek AL; Havenith RW; Hartl F; van Klink GP; van Koten G
    Inorg Chem; 2007 Dec; 46(26):11133-44. PubMed ID: 18052055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors.
    Bratsos I; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008 Apr; 102(4):606-17. PubMed ID: 18063052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic ability of a cationic Ru(II) monochloro complex for the asymmetric hydrogenation of dimethyl itaconate and enamides.
    Serrano I; Rodríguez M; Romero I; Llobet A; Parella T; Campelo JM; Luna D; Marinas JM; Benet-Buchholz J
    Inorg Chem; 2006 Mar; 45(6):2644-51. PubMed ID: 16529487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new dinuclear Ru-Hbpp based water oxidation catalyst with a trans-disposition of the Ru-OH.
    Mola J; Dinoi C; Sala X; Rodríguez M; Romero I; Parella T; Fontrodona X; Llobet A
    Dalton Trans; 2011 Apr; 40(14):3640-6. PubMed ID: 21384040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The crucial role of the diphosphine heteroatom X in the stereochemistry and stabilization of the substitution-inert [M(N)(PXP)]2+ metal fragments (M = Tc, Re; PXP = diphosphine ligand).
    Tisato F; Refosco F; Porchia M; Bolzati C; Bandoli G; Dolmella A; Duatti A; Boschi A; Jung CM; Pietzsch HJ; Kraus W
    Inorg Chem; 2004 Dec; 43(26):8617-25. PubMed ID: 15606213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
    Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel iron(III) complexes of sterically hindered 4N ligands: regioselectivity in biomimetic extradiol cleavage of catechols.
    Mayilmurugan R; Stoeckli-Evans H; Palaniandavar M
    Inorg Chem; 2008 Aug; 47(15):6645-58. PubMed ID: 18597419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron(III) complexes of tripodal monophenolate ligands as models for non-heme catechol dioxygenase enzymes: correlation of dioxygenase activity with ligand stereoelectronic properties.
    Mayilmurugan R; Visvaganesan K; Suresh E; Palaniandavar M
    Inorg Chem; 2009 Sep; 48(18):8771-83. PubMed ID: 19694480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward controlling water oxidation catalysis: tunable activity of ruthenium complexes with axial imidazole/DMSO ligands.
    Wang L; Duan L; Stewart B; Pu M; Liu J; Privalov T; Sun L
    J Am Chem Soc; 2012 Nov; 134(45):18868-80. PubMed ID: 23062211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.